share_log

Akanda Corp. Secures Hemp Cultivation License in Canada, Building on Previous Development Agreement

Akanda Corp. Secures Hemp Cultivation License in Canada, Building on Previous Development Agreement

Akanda公司在加拿大獲得大麻種植許可證,繼續之前的發展協議。
newsfile ·  09/16 12:40

London, United Kingdom--(Newsfile Corp. - September 16, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), a global cannabis company, is excited to announce that it has obtained a license for hemp cultivation in Canada. This license is directly tied to Akanda's previously announced agreement with 1107385 B.C. LTD, further advancing the company's strategic initiatives in the Canadian cannabis market.

英國倫敦-(新聞稿公司-2024年9月16日)-Akanda股份公司(納斯達克:AKAN)("Akanda"或"公司"),一家全球大麻公司,很高興宣佈已獲得在加拿大進行大麻種植的許可。該許可證直接與Akanda此前宣佈的與11073850億.C. LTD的協議相關聯,進一步推進了該公司在加拿大大麻市場的戰略倡議。

This latest development highlights Akanda's commitment to executing its strategic vision and solidifying its role as a leader in the global cannabis industry.

此最新進展突顯了Akanda對執行其戰略願景並鞏固在全球大麻行業中的領導地位的承諾。

About Akanda Corp.

關於Akanda corp。

Akanda is an international medical cannabis and wellness platform company seeking to help people lead better lives through improved access to high quality and affordable products. Akanda's portfolio includes CanMart, a UK-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the UK. The Company's seed-to-patient supply chain also includes partnerships Cellen Life Sciences' Leva Clinic, one of the first fully digital pain clinics in the UK. Akanda also acquired the right to develop a Canadian farming property in British Columbia, including farming land and related operations and licenses. The Company plans to develop THC and cannabinoid (CBD) facilities at this site.

Akanda是一家國際醫用大麻和健康平台公司,旨在通過改善高品質和價格實惠產品的獲得,幫助人們過上更好的生活。Akanda的投資組合包括CanMart,是總部位於英國的全牌照藥品進口商和經銷商,向英國內的藥店和診所提供產品。該公司的種子患者供應鏈還包括與Cellen Life Sciences' Leva Clinic 的合作關係,後者是英國首批全數字化疼痛診所之一。Akanda還獲得了在不列顛哥倫比亞省開發農場和相關經營和許可的權利。公司計劃在該地點開發THC和大麻二酚(CBD)設施。

Connect with Akanda: Email | Website | LinkedIn | Twitter | Instagram

聯繫Akanda:電子郵箱|網站|領英|推特|Instagram

Investor Contact
ir@akandacorp.com

投資者聯繫方式
ir@akandacorp.com

Cautionary Note Regarding Forward-Looking Information and Statements

關於引言中的前瞻性信息和聲明的注意事項

This press release contains certain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only Akanda's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Akanda's control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". Forward-looking statements may relate to anticipated events or results including, but not limited to business strategy, product development and sales and growth plans. The forward-looking statements contained in this press release are made as of the date of this press release, and Akanda does not undertake to update any forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

本新聞發佈內容中包含可能構成《1995年美國私有證券訴訟改革法案》安全港條款所指之"前瞻性聲明"。此類前瞻性聲明並非代表歷史事實、信息或當前狀況,而是隻代表Akanda關於未來事件、計劃或目標的信念,其中許多本質上是不確定及在Akanda控制範圍之外的事項。通常,此類前瞻性聲明可通過使用"計劃"、"預計"或"不預計"、"預期的"、"預算"、"排程"、"估計"、"預測"、"打算"、"預期"或"不預期"、"相信"等前瞻性術語來識別,或可能包含表明某些行動、事件或結果"可能"、"可能"、"可能"、"可能"或"將被採取"、"將繼續"、"將發生"或"將實現"的陳述。前瞻性聲明可能涉及預期的事件或結果,包括但不限於業務戰略、產品開發和銷售以及增長計劃。本新聞發佈中所包含的前瞻性聲明截至發佈日期,Akanda不承諾更新任何包含或提及於此的前瞻性聲明,除符合適用證券法規之外。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論